Glycogen Synthase Kinase 3 Regulates N-Methyl-d-aspartate Receptor Channel Trafficking and Function in Cortical Neurons

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular Pharmacology

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/mol.107.034942PMID 17400762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Positive Feedback Loop between Glycogen Synthase Kinase 3β and Protein Phosphatase 1 after Stimulation of NR2B NMDA Receptors in Forebrain Neurons*

  2005cited by this paper
• The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2.

  2005cited by this paper
• GSK-3β and Microtubule Assembly in Axons

  2005cited by this paper
• Microtubule Regulation of N-Methyl-D-aspartate Receptor Channels in Neurons*

  2005cited by this paper
• Cell biology. GSK-3beta and microtubule assembly in axons.

  2005cited by this paper
• Serotonin 5-HT1A Receptors Regulate NMDA Receptor Channels through a Microtubule-Dependent Mechanism

  2005influential reference
• Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex

  2005cited by this paper
• NMDA receptor-dependent activation of the small GTPase Rab5 drives the removal of synaptic AMPA receptors during hippocampal LTD.

  2005cited by this paper
• Protein Kinase B/Akt Acts via Glycogen Synthase Kinase 3 To Regulate Recycling of αvβ3 and α5β1 Integrins

  2004cited by this paper
• Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

  2004cited by this paper
• Pharmacological inhibitors of glycogen synthase kinase 3.

  2004cited by this paper
• Subunit-Specific Regulation of NMDA Receptor Endocytosis

  2004cited by this paper
• The glamour and gloom of glycogen synthase kinase-3.

  2004cited by this paper
• Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.

  2004cited by this paper
• GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

  2003influential reference
• Glutamatergic mechanisms in schizophrenia.

  2003cited by this paper
• GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

  2003influential reference
• MinireviewFinding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments

  2003cited by this paper
• Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity

  2003cited by this paper
• Trafficking of NMDA receptors.

  2003cited by this paper
• GSK-3: tricks of the trade for a multi-tasking kinase

  2003cited by this paper
• Molecular targets of lithium action

  2003cited by this paper
• Regulation of NMDA Receptors by Dopamine D4 Signaling in Prefrontal Cortex

  2003influential reference
• Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions

  2002cited by this paper
• An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling

  2002cited by this paper
• Differential regulation of synaptic and extra-synaptic NMDA receptors

  2002cited by this paper
• Alzheimer's Disease Is a Synaptic Failure

  2002cited by this paper
• Functional expression of distinct NMDA channel subunits tagged with green fluorescent protein in hippocampal neurons in culture.

  2002influential reference
• Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin‐based motility

  2002cited by this paper
• Rab proteins as membrane organizers

  2001cited by this paper
• GSK3 takes centre stage more than 20 years after its discovery.

  2001cited by this paper
• The renaissance of GSK3

  2001cited by this paper
• Molecular determinants of NMDA receptor internalization

  2001influential reference
• Three rat brain alternative splicing dynamin-like protein variants: interaction with the glycogen synthase kinase 3beta and action as a substrate.

  2000cited by this paper
• Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport.

  2000cited by this paper
• Role of phosphorylation in regulation of the assembly of endocytic coat complexes.

  1998cited by this paper
• Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3*

  1997influential reference
• GSK3: a SHAGGY frog story.

  1996cited by this paper
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

  1995influential reference
• Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis.

  1994cited by this paper
• Identification and Characterization of Protein Kinase FA/ Glycogen Synthase Kinase 3 in Clathrin‐Coated Brain Vesicles

  1993cited by this paper
• The GTPase dynamin binds to and is activated by a subset of SH3 domains.

  1993cited by this paper
• The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway.

  1992cited by this paper

• GSK3B inhibition partially reverses brain ethanol-induced transcriptomic changes in C57BL/6J mice: Expression network co-analysis with human genome-wide association studies

  2025cites this paper
• Unlocking the therapeutic potential of protein kinase inhibitors in neurodegenerative and psychiatric disorders

  2025cites this paper
• Immune control of the basal ganglia network: Interleukin-17 as a key modulator of striatal synaptic plasticity.

  2025cites this paper
• IGF1 enhances memory function in obese mice and stabilizes the neural structure under insulin resistance via AKT-GSK3β-BDNF signaling.

  2025cites this paper
• Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer's diseases therapy.

  2024cites this paper
• The lemur tail kinase family in neuronal function and disfunction in neurodegenerative diseases

  2024cites this paper
• Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach.

  2024cites this paper
• Effects of memantine on mania‐like phenotypes exhibited by Drosophila Shaker mutants

  2023cites this paper
• Astroglia-derived TIMP-1 alleviates cognitive deficits by restoring synaptic plasticity in Alzheimer’s disease

  2023cites this paper
• The complex molecular pharmacology of the dopamine D2 receptor: Implications for pramipexole, ropinirole, and rotigotine.

  2023cites this paper
• Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia

  2023cites this paper
• Na+,K+-ATPase and Cardiotonic Steroids in Models of Dopaminergic System Pathologies

  2023cites this paper
• Pharmacological modulation of autophagy for epilepsy therapy: opportunities and obstacles.

  2023cites this paper
• An astrocyte-derived cytokine TIMP-1 restores synaptic plasticity in an Alzheimer’s disease model

  2023cites this paper
• Circadian rhythms as modulators of brain health during development and throughout aging

  2023cites this paper
• Small molecules targeting endocytic uptake and recycling pathways

  2023cites this paper
• Role of Aβ in Alzheimer’s-related synaptic dysfunction

  2022cites this paper
• Early synaptic deficits in GSK-3β overexpressing mice.

  2022cites this paper
• Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression

  2021cites this paper
• GSK-3 and Tau: A Key Duet in Alzheimer’s Disease

  2021influential citation
• Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential

  2021cites this paper
• GSK3β Activity in Reward Circuit Functioning and Addiction

  2021cites this paper
• Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction?

  2020cites this paper
• Deletion of Glycogen Synthase Kinase-3 β in D 2 Receptor-Positive Neurons Ameliorates Cognitive Impairment via N -Methyl-D-Aspartate Receptor-Dependent Synaptic Plasticity

  2020cites this paper
• Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes

  2020cites this paper
• mTOR-Related Cell-Clearing Systems in Epileptic Seizures, an Update

  2020cites this paper
• Glycogen synthase kinase-3 signaling in cellular and behavioral responses to psychostimulant drugs.

  2020cites this paper
• Glycogen synthase kinase‐3ß supports serotonin transporter function and trafficking in a phosphorylation‐dependent manner

  2020cites this paper
• GSK-3-TSC axis governs lysosomal acidification through autophagy and endocytic pathways.

  2020cites this paper
• Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?

  2020cites this paper
• Control of neuronal excitability by GSK-3beta: epilepsy and beyond.

  2020cites this paper
• β -Amyloid Impairs the Regulation of NMDA Receptors by Glycogen Synthase Kinase 3

  2020cites this paper
• The forebrain synaptic transcriptome is organized by clocks but its proteome is driven by sleep

  2019cites this paper
• NO-sGC-cGMP signaling influence the anxiolytic like effect of lithium in mice in light and dark box and elevated plus maze.

  2019cites this paper
• The neuroprotective mechanism of cinnamaldehyde against amyloid-β in neuronal SHSY5Y cell line: The role of N-methyl-D-aspartate, ryanodine, and adenosine receptors and glycogen synthase kinase-3β

  2019cites this paper
• Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies.

  2019cites this paper
• The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons

  2019cites this paper
• GSK-3β at the Intersection of Neuronal Plasticity and Neurodegeneration

  2019cites this paper
• Phytic acid attenuates upregulation of GSK-3β and disturbance of synaptic vesicle recycling in MPTP-induced Parkinson's disease models.

  2019cites this paper
• Excitotoxic targeting of Kidins220 to the Golgi apparatus precedes calpain cleavage of Rap1-activation complexes

  2019cites this paper
• Small molecule inhibition of PIKFYVE kinase rescues gain- and loss-of-function C9ORF72 ALS/FTD disease processes in vivo

  2019cites this paper
• Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models

  2019cites this paper
• GSK‐3β regulates the synaptic expression of NMDA receptors via phosphorylation of phosphatidylinositol 4 kinase type IIα

  2019influential citation
• Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons.

  2019cites this paper
• Deletion of Glycogen Synthase Kinase-3β in D2 Receptor-Positive Neurons Ameliorates Cognitive Impairment via NMDA Receptor-Dependent Synaptic Plasticity.

  2019cites this paper
• Lithium Inhibits GSK3β and Augments GluN2A Receptor Expression in the Prefrontal Cortex

  2018cites this paper
• Molecular Brain Adaptations to Ethanol: Role of Glycogen Synthase Kinase-3 Beta in the Transition to Excessive Consumption

  2018cites this paper
• Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons

  2018influential citation
• Phosphorylation and SUMOylation of CRMP2 regulate the formation and maturation of dendritic spines.

  2018cites this paper
• Circadian Regulation of Hippocampal-Dependent Memory: Circuits, Synapses, and Molecular Mechanisms

  2018cites this paper
• Deletion of dopamine D2 receptors from parvalbumin interneurons in mouse causes schizophrenia-like phenotypes

  2018cites this paper
• Disparate Effects of Lithium and a GSK-3 Inhibitor on Neuronal Oscillatory Activity in Prefrontal Cortex and Hippocampus

  2018cites this paper
• Juvenile treatment with mGluR2/3 agonist prevents schizophrenia‐like phenotypes in adult by acting through GSK3&bgr;

  2018cites this paper
• GSK3β activity alleviates epileptogenesis and limits GluA1 phosphorylation

  2018cites this paper
• Role of Akt-independent mTORC1 and GSK3β signaling in sublethal NMDA-induced injury and the recovery of neuronal electrophysiology and survival

  2017cites this paper
• Synaptic roles of cyclin-dependent kinase 5 & its implications in epilepsy

  2017cites this paper
• Alleviation of N-Methyl-d-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3β Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism

  2017cites this paper
• GSK3β Controls mTOR and Prosurvival Signaling in Neurons

  2017cites this paper
• GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation

  2017cites this paper
• Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine via Regulating the Trafficking and Function of Spinal NMDA Receptors as well as PKC and CaMKII Level In Vivo and In Vitro

  2017cites this paper
• Neuroprotective effects of resveratrol against traumatic brain injury in rats: Involvement of synaptic proteins and neuronal autophagy.

  2016cites this paper
• Gsk3 Signalling and Redox Status in Bipolar Disorder: Evidence from Lithium Efficacy

  2016cites this paper
• Synaptic Wnt/GSK3β Signaling Hub in Autism

  2016cites this paper
• Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System.

  2016cites this paper
• Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex.

  2016cites this paper
• The Convergence of Glutamate and GABA Dysregulation in Schizophrenia

  2016cites this paper
• Dimensions of GSK3 Monoamine-Related Intracellular Signaling in Schizophrenia

  2016cites this paper
• GSK-3β and MMP-9 Cooperate in the Control of Dendritic Spine Morphology

  2016cites this paper
• Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

  2015cites this paper
• Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

  2015cites this paper
• Glycine transporters GlyT1 and GlyT2 are differentially modulated by glycogen synthase kinase 3β.

  2015influential citation
• Lentiviral silencing of GSK-3β in adult dentate gyrus impairs contextual fear memory and synaptic plasticity

  2015cites this paper
• Structural Plasticity of Dendritic Spines Requires GSK3α and GSK3β

  2015cites this paper
• Tideglusib protects neural stem cells against NMDA receptor overactivation

  2015cites this paper
• Rescue of impaired late-phase long-term depression in a tau transgenic mouse model.

  2015cites this paper
• Blocking GSK3β-mediated dynamin1 phosphorylation enhances BDNF-dependent TrkB endocytosis and the protective effects of BDNF in neuronal and mouse models of Alzheimer's disease.

  2015cites this paper
• Hydrogen-rich saline controls remifentanil-induced hypernociception and NMDA receptor NR1 subunit membrane trafficking through GSK-3β in the DRG in rats.

  2014cites this paper
• Strategizing the Development of Alzheimer’s Therapeutics

  2014cites this paper
• Synergistic Regulation of Glutamatergic Transmission by Serotonin and Norepinephrine Reuptake Inhibitors in Prefrontal Cortical Neurons*

  2014cites this paper
• Alteration in Synaptic Junction Proteins following Traumatic Brain Injury

  2014cites this paper
• Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.

  2014cites this paper
• PI4KIIα phosphorylation by GSK3 directs vesicular trafficking to lysosomes.

  2014cites this paper
• The glial perspective of autism spectrum disorders.

  2014cites this paper
• β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3.

  2014cites this paper
• Dopamine D1-D2 Receptor Heteromer Regulates Signaling Cascades Involved in Addiction: Potential Relevance to Adolescent Drug Susceptibility

  2014cites this paper
• Bis(12)-hupyridone, a novel acetylcholinesterase inhibitor, protects against glutamate-induced neuronal excitotoxicity via activating α7 nicotinic acetylcholine receptor/phosphoinositide 3-kinase/Akt cascade.

  2013cites this paper
• Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice.

  2013cites this paper
• Glycogen Synthase Kinase-3&bgr; Contributes to Remifentanil-Induced Postoperative Hyperalgesia via Regulating N-Methyl-D-Aspartate Receptor Trafficking

  2013cites this paper
• Understanding the relationship between GSK-3 and Alzheimer’s disease: a focus on how GSK-3 can modulate synaptic plasticity processes

  2013cites this paper
• Aβ(1-42) induced metabolic effects in a stem cell derived neuron and astrocyte network

  2013cites this paper
• b -Amyloid impairs the regulation of N -methyl-D-aspartate receptors by glycogen synthase kinase 3 Neurobiology of Aging

  2013cites this paper
• Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia

  2013cites this paper
• Inhibition of Glycogen Synthase Kinase-3β Prevents Remifentanil-Induced Hyperalgesia via Regulating the Expression and Function of Spinal N-Methyl-D-Aspartate Receptors In Vivo and Vitro

  2013cites this paper
• Excessive activation of the loop between the NR2B subunit of the N-methyl-d-aspartate receptor and glycogen synthase kinase-3β in the hippocampi of patients with major depressive disorder

  2012influential citation
• In vitro and in vivo Anti-plasmodial Activities of Gynura procumbens (Kajian in vitro dan in vivo Aktiviti Anti-plasmodium Gynura procumbens)

  2012cites this paper
• Animal Models of Prophylaxis and Prevention of Schizophrenia: Prenatal Seasonal Influenza Vaccine and Postnatal Valproate

  2012cites this paper
• Serine Phosphorylation of the Insulin-like Growth Factor I (IGF-1) Receptor C-terminal Tail Restrains Kinase Activity and Cell Growth*

  2012cites this paper
• Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine.

  2012cites this paper
• Hyperdopaminergic modulation of inhibitory transmission is dependent on GSK‐3β signaling‐mediated trafficking of GABAA receptors

  2012cites this paper
• GSK3 as a Sensor Determining Cell Fate in the Brain

  2012cites this paper